This study examined the relation between synthesis, atrial storage, and plasma levels of atrial natriuretic peptide (ANP), and it examined plasma ANP levels and hemodynamic output in response to volume expansion in a rat model of myocardial infarction and failure. Arterial ANP concentrations did not correlate linearly with infarct size, but they did show an abrupt increase when infarct size exceeded 30% of the left ventricle, similar to the abrupt increase of left ventricular end-diastolic pressure with infarct size greater than 30%. Consequently, a close relation was found between plasma ANP levels and left ventricular end-diastolic pressure (n =23, r=0.89, p < 0.001). Atrial ANP content per gram of tissue but not ANP content per pair of atria was reduced in rats with large infarcts (> 40%,p < 0.05 vs. control animals). ANP mRNA level per pair of atria (related to total atrial RNA), determined by liquid hybridization (controlled by northern blot analysis), was increased by 38% in infarcted rats (p<O0.05 vs. controls), but the ratio of atrial ANP mRNA relative to atrial j3-actin mRNA levels was not increased. Right and left ventricular ANP mRNA level increased by 90% and 380%, respectively, far exceeding the concomitant increase in f,-actin mRNA (+26% in the left ventricle). Plasma ANP increased with volume loading in controls and rats with moderate infarcts but not in rats with large infarcts despite a similar increase in right atrial pressure (compared with control animals); thus, the relation of AANP/Aright atrial pressure exerted by volume loading decreased in rats with large infarcts. Similarly, the response of cardiac output and renal blood flow (determined by radioactive microspheres) to volume loading was attenuated in rats with large infarcts. Thus, in this model of chronic cardiac failure, the activation of the ANP system is closely coupled with the increase in intracardiac pressures without correlating linearly to the extent of myocardial loss. Second, in severe cardiac failure, additional stimulation such as volume loading may elicit only an attenuated ANP secretion response, for example, due to saturation of the ANP receptor sensing system or to a limited transformation rate of pro-ANP. Third, the increase in atrial ANP synthesis and the increase in atrial ANP gene expression seems limited; however, substantial specific ANP gene expression occurs in the ventricles, which, in turn, may contribute to increased plasma ANP levels in chronic heart failure. (Circulation 1989;79:620-633) P revious studies showed that an atrial factor that induces natriuresis and diuresis is released from rat heart-lung preparations in
ventricular ANP mRNA level increased by 90% and 380%, respectively, far exceeding the concomitant increase in f,-actin mRNA (+26% in the left ventricle). Plasma ANP increased with volume loading in controls and rats with moderate infarcts but not in rats with large infarcts despite a similar increase in right atrial pressure (compared with control animals); thus, the relation of AANP/Aright atrial pressure exerted by volume loading decreased in rats with large infarcts. Similarly, the response of cardiac output and renal blood flow (determined by radioactive microspheres) to volume loading was attenuated in rats with large infarcts. Thus, in this model of chronic cardiac failure, the activation of the ANP system is closely coupled with the increase in intracardiac pressures without correlating linearly to the extent of myocardial loss. Second, in severe cardiac failure, additional stimulation such as volume loading may elicit only an attenuated ANP secretion response, for example, due to saturation of the ANP receptor sensing system or to a limited transformation rate of pro-ANP. Third, the increase in atrial ANP synthesis and the increase in atrial ANP gene expression seems limited; however, substantial specific ANP gene expression occurs in the ventricles, which, in turn, may contribute to increased plasma ANP levels in chronic heart failure. (Circulation 1989;79:620-633) P revious studies showed that an atrial factor that induces natriuresis and diuresis is released from rat heart-lung preparations in response to high atrial perfusion pressure.1 Right atrial appendectomy has reduced the renal response to acute hypervolume in the rat,2 and release of immunoreactive atrial natriuretic peptide (ANP) from isolated rat hearts in response to volume loading has been shown. 3 Plasma ANP concentrations are elevated in patients with pressure or volume overload, such as hypertension, renal failure, or congestive heart failure4, 5, 6 and from secondary to increased atrial stretch. 7 Conversely, recent studies indicated that cardiac atria of the Syrian hamster with cardiomyopathy or rats with myocardial infarction are deficient in ANP when measured per gram of tissue.8 9 Furthermore, ANP messenger RNA was recently shown to increase in a rat model of circulatory failure due to aortal-caval shunt,10 indicating that atrial ANP synthesis and turnover is increased in heart failure. Additional stimuli (such as volume loading) in this situation may elicit only limited secretion of ANP into the circulation. However, significant increases in ANP content and ANP mRNA in ventricles were observed in recent studies, suggesting that the ventricle could be an important source of ANP in congestive heart failure.10"11
To investigate biosynthesis, storage, and the mechanisms of ANP secretion in heart failure, we measured atrial and ventricular ANP mRNA levels, atrial content of ANP, plasma ANP levels, and the effects of volume loading in a rat model of myocardial infarction and failure.12"3 Specific ANP mRNA and f3-actin mRNA levels in atrial and ventricular tissue were measured simultaneously to determine whether or not the changes in ANP mRNA levels are specific and not merely markers of overall protein synthesis.
Methods

Experimental Preparations
Infarction was produced by left coronary arterial ligation as described previously14 and as modified by MacLean et al. 15 In male Sprague-Dawley rats, the left coronary artery was ligated approximately 2 mm from its origin with a 6-0 suture. In the shamoperated rats, the suture was tied loosely so as not to obstruct coronary flow. With this method, the 24-hour mortality rate was 40% for the infarction group and 5% for the sham-operated group. The surviving rats were maintained on standard rat chow, and subsequent experimental procedures were started 23 (range, [22] [23] [24] +5 ,um in diameter, were used to measure regional blood flow and cardiac output with the reference sample technique17 as adapted for use in the rat.18 A detailed presentation of the radioactive microsphere technique used in this study has been described. 16 In brief, the microspheres suspension was thoroughly mixed by agitation and sonication (Branson Sonifier B-30, Danbury, Connecticut) immediately before each injection. Approximately 250,000 microspheres (0.5 ml) was then injected into the left ventricle during a 15-second period followed immediately by a 0.5-ml heparinized saline flush during a 15-second period. To obtain the reference sample, arterial blood was withdrawn (beginning 15 seconds before and continuing during the injection of microspheres) through the tail artery at a rate of 0.35 ml/ min maintained by a Harvard constant flow pump (Model 906, South Natick, Massachusetts). The total blood withdrawal period was 1.5 minutes for each injection and was used as the blood flow reference sample. Immediately afterward, 0.5 ml blood was withdrawn for measuring plasma ANP levels.
At the end of the study, animals were killed by phenobarbital injection in the ventricle, and organs and tissue samples were removed. All samples were immediately blotted, weighed, and transferred to a two-channel Gamma scintillation counter (Kontron 480 AR, Munich, FRG) for measuring radioactivity levels. A Digital Equipment Professional 350 computer was used to calculate regional blood flow and total cardiac output. 19 
Hemodynamic Output
Tracings from the left ventricular, right atrial, and caudal catheter were recorded continuously during the experimental protocol and were used to obtain heart rate, left ventricular peak systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), mean right atrial pressure (RAP), and mean arterial pressure (MAP) ( and the SP 6-Polymerase-promotor systems described by Melton et al. 23 Total RNA was prepared by the LiCl-urea technique.24 After quantification by absorption at 260 nm, a predetermined amount of RNA was denatured in glyoxal, loaded on a 1% agarose gel, fractionated electrophoretically, and blotted to nitrocellulose paper. Hybridization was done in 50% formamid, 50 mM Naphosphate, pH 6.8, 1 M NaCI, 200 jug/ml herring sperm DNA, 5xDenhardt, 0.1% sodium dodecyl sulfate (SDS), and 10 mM NaEDTA for 18 hours at 650 C. Liquid hybridization was done with a modified procedure described by Durnam and Palmiter.25 Hybridization total RNA was dissolved in 30 ,ul hybridization buffer [40% formamid, 40 mM piperazine-N,N'-bis(2-ethanesulfonic acid), 0.4 M NaCl, 1 mM NaEDTA, and 1,000 cpm ANP-cRNA/ ,ul] and incubated for 18 hours at 700 C. After RNAase treatment (dilution in a 10-fold volume of 0.3 M NaCI, 10 mM Tris buffer, pH 7.4, 5 mM NaEDTA, incubated for 1 hour at 30°C), intact cRNA-mRNA hybrid was precipitated with 10% trichloroacetic acid, the precipitate was collected in a nitrocellulose filter, and radioactivity was counted in a ,l-scintillation counter. The amount of hybridized mRNA was calculated from the radioactivity of the precipitate and the specific activity of the cRNA probe. Results were then expressed as picogram of mRNA per microgram of total RNA.
Protocol 2
Hemodynamic output (similar to protocol 1) was monitored during 30 minutes, and radioactive microspheres were injected at the end of this baseline period (infarcted group: n = 11; body weight, 388 +21 g; sham-operated group: n = 12; body weight, 367 ± 18 g). Arterial blood was withdrawn from the tail artery for measuring cardiac output as described above, and a second sample was obtained for measuring plasma ANP levels (approximately 2 minutes after injection of microspheres). Three minutes after starting the saline infusion (identical to protocol 1), the injection of microspheres was repeated for measuring cardiac output and regional blood flow. This short time lag between saline infusion and injection of microspheres was selected because earlier experiments3 showed that plasma ANP should rise to maximal levels within 5 minutes.3 Injection of microspheres and a 2-minute time period before blood sampling, similar to the protocol for obtaining control measurements, resulted in a maximal rise of ANP levels during the anticipated time period of 5 minutes. The animals were killed by injecting phenobarbital into the left ventricle, and the tissues including heart and kidneys were removed for rscintillation analysis (Kontron 480 AR). The primary objective of this second protocol (opposed to protocol 1) was to evaluate the systemic and regional vascular effects after increased plasma ANP levels induced by volume loading. Withdrawal of 0.5 ml blood for measuring ANP plasma levels and removal of blood in the catheter dead space makes up to 1 ml of blood, which may influence regional vascular blood flow by activating neurohumoral effects. Therefore, blood for measuring ANP plasma levels was withdrawn after injecting microspheres (which includes withdrawal of 0.5 ml of blood for measuring cardiac output), although it was anticipated that the volume load associated with the injection of microspheres would increase the plasma ANP concentration. Protocol 3 The hearts of seven sham-operated animals (body weight, 409±14 g) and 11 infarcted animals (body weight, 424±17 g) were excised 41±3 days after surgery. Atria (right and left atria together) and the right and left ventricles were separated, weighed, and frozen in liquid nitrogen. Special attention was paid to the separation of atrial and ventricular myocardium. Therefore, after weighing the tissues, the edges of the base of right and left ventricles were cut to exclude contamination of right or left ventricular myocardium with atrial tissue. The scar tissue of the left ventricle was separated, and only viable myocardium of the left ventricle (hypertrophied inferior wall and septum) was used for measuring mRNA. The infarct size of the left ventricle was estimated based on the total weight of the left ventricle and the size of the scar tissue (infarcted area). Although less accurate than histologic measurement of infarct size, this method yields infarct sizes similar to histologic planimetry (unpublished observation from this laboratory).
The ANP-specific cRNA hybridization probe was prepared as described above. For preparation of actin-specific cRNA hybridization probe, a 640-base Sal I-EcoRI fragment of ,B-actin-like pseudogene was subcloned into pGEM4 plasmid. 26 The Hind III-linearized plasmid served as template for transcription with SP6 Polymerase as described for ANP. Total RNA was prepared by the LiClurea technique.24 After quantification by absorption at 260 nm, 2.5 ,ug RNA was denatured in 1 M glyoxal, pH 5, 50% dimethyl sulfoxide, 0.01 M Na-phosphate, pH 7, loaded on a 1.2% agarose gel, fractionated electrophoretically, and blotted to nytran 13N membrane. Hybridization was done in 50% formamid, 50 mM Na-phosphate, pH 7, 1 M NaCl, 200 ,ug/ml salmon sperm DNA, 200 pig/ml yeast RNA, 5 x Denhardt, 0.2% SDS, and 10 mM NaEDTA for 3 hours at 700 C. Then, 2 x 10 cpm/ml /3-actin and ANP probe, respectively, were added to the hybridization mix, and incubation was continued for a further 18 hours. The membranes were washed in 0.1 x 15 mM NaCl and 1.5 mM Na-citrate, 0.1% SDS at room temperature and at 700 C and then exposed to radiographic film with intensifying screens at -70°C. The specific bands of ,B-actin and ANP were cut, and radioactivity was measured in a ,/-scintillation counter. In the case of the atria blots, ANP and f8-actin hybridization was performed separately because of a very strong ANP signal compared with the /3-actin signal.
Statistical Analysis
Data are reported as mean ± SEM. Student's t test and analysis of variance followed by StudentNewman-Keuls test were used to determine statistical significance of differences. Figure 1 (top panel) shows the relation of LVEDP to infarct size, indicating that LVEDP is consistently increased when infarct size exceeds the 30% level. Arterial ANP concentrations did not correlate linearly with infarct size but showed the same abrupt increase (compared with LVEDP) when the infarct size exceeded 30% (Figure 1, middle panel) . However, the arterial plasma ANP levels were closely correlated with LVEDP ( Figure 1 , bottom panel). In 12 infarcted rats, in which reliable measurements of right atrial pressure were obtained, the correlation between arterial ANP levels and RAP yielded r= 0.612, p<0.05. Atrial immunoreactive ANP concentration per gram of tissue was decreased in animals with large infarcts (>40%), whereas no difference was found between control rats and rats with infarcts less than 30% (Figure 2) . However, when atrial ANP content was expressed per total weight of both atria, no differences were found between rats with large infarcts and shamoperated rats. In Figure 3 , the atrial ANP mRNA per total RNA (determined by liquid hybridization) is plotted against infarct size. The validity of the liquid hybridization data was controlled by northern blotting in a smaller number of hearts, yielding similar results. The atrial ANP mRNA content was increased (by more than 2 SD of the mean of the control group) only in rats with large infarcts ( > 40%), which corresponds to the reduced atrial ANP content per pair of atria in these animals ( Figure 2) . In a separate group of animals, atrial ANP mRNA per total RNA was increased in infarcted rats compared with sham-operated rats (+ 38%, p < 0.05) ( Figure  4 ). Infarct size of the latter group averaged 33 ±4% (range, 25-40%) of the left ventricle, and the weights of atria and right ventricle were significantly higher than in the corresponding sham-operated animals (atria, 0.29±0.04 vs. 0.45±0.07 g; right ventricle, 0.62 ± 0.05 vs. 0.84 ± 0.06 g; p < 0.05 sham-operated vs. infarcted). The atrial 13-actin mRNA per total RNA of sham-operated and infarction groups did not differ significantly, although a slight increase occurred in the infarction group (+ 13%) (Figure 4) .
However, the ratio of atrial ANP mRNA to f8-actin mRNA was not significantly elevated in the infarction group (10.1 vs. 8.9), indicating that the increase in ANP mRNA relative to fl-actin mRNA may not be specific in this group of animals ( Figure   5 ). In contrast, the ratio of ANP mRNA to f3-actin mRNA was substantially increased in both ventricles in the infarction group compared with the sham-operated group ( Figure 5) .
The right and left ventricular ANP mRNA levels were 1.9 and 3.8 times higher (+90% and 380%) in the infarction groups than in sham-operated animals (Figures 4 and 6 ). In contrast, right and left ventricular /3-actin mRNA levels of infarction and shamoperated groups did not differ significantly ( Figures  4 and 6) .
Thus, despite significant ventricular hypertrophy and increased overall protein synthesis in this setting, a marked specific increase in ANP mRNA was found in both ventricles in this model of myocardial infarction and failure.
The plasma ANP levels of animals with moderate infarcts ( < 30%) were higher than in control animals; however, the difference was not significant because of the wide range of the ANP concentrations of this infarcted group. However, the plasma levels in animals with large infarcts were substantially and significantly higher than in control animals and in animals with moderate infarcts (Figure 7) . After volume loading, the plasma concentrations of ANP did not increase in animals with large infarcts. In rats with moderate infarcts (<30%) and in the control group, a significant increase in plasma synthesis and turnover, possibly combined with a n .
-_--- nism for the release of ANP cannot be totally excluded from the present data, this interpretation seems unlikely from our analysis of the relation between /ANP and ARAP in these animals ( Figure  8 , Table 2 
